G2GBIO Inc. (KOSDAQ:456160)
36,000
-4,200 (-10.45%)
At close: Jun 26, 2026
G2GBIO Market Cap
G2GBIO has a market cap or net worth of 723.03 billion as of June 29, 2026.
Market Cap
723.03B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
36,000.00
Market Cap Chart
Since August 14, 2025, G2GBIO's market cap has increased from 503.30B to 723.03B, an increase of 43.66%. That is a compound annual growth rate of 51.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 595.63B | -45.86% |
| Dec 30, 2025 | 1.10T | 118.59% |
| Aug 14, 2025 | 503.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samyang Biopharm | 317.14B |
| HEM Pharma | 299.61B |
| ImmuneOncia Therapeutics | 291.16B |
| NOVAREX | 199.55B |
| CellBion | 192.29B |
| DAE HWA Pharmaceutical | 153.62B |
| Vivozon Pharmaceutical | 149.81B |
| High Tech Pharm | 135.15B |